The opponents of Issue 2, the Drug Price Relief Act, recently outspent backers of that proposal by a four to one margin. And most of the money in the opposition’s campaign war chest couldn’t be directly traced because it was in an LLC rather than a traditional political action committee. This has raised questions once again about campaign finance reform, something both the Democrat and Republican candidates say is needed.